Maximilian Papi
Rimini, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 09, 2024
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs.
Journal: Journal of clinical medicine
Published: March 02, 2020
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 29, 2019
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR).
Journal: Journal of thoracic disease
Published: September 21, 2018
Antimetabolites in the treatment of advanced pleural mesothelioma: a network meta-analysis of randomized clinical trials.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 13, 2017
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 19, 2016
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
Journal: Clinical lung cancer
Published: September 04, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?
Journal: International journal of molecular sciences
Published: October 17, 2014
Gemcitabine and paclitaxel combination as second-line chemotherapy in patients with small-cell lung cancer: a phase II study.
Journal: Clinical lung cancer
Published: January 18, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026